As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...

There are huge stakes for health care in the upcoming U.S. election — and leaders from across the political spectrum weighed in on policy ...

After hitting a wall with the FDA last year, Novo Nordisk has picked up backing from European drug reviewers for its novel ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Pfizer Inc. defeated a proposed class action challenging the administrative fees in its $21 billion 401(k) plan when a ...

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Trodelvy’s next big readout is EVOKE-03, which is testing the Gilead drug with Merck’s PD-1 inhibitor Keytruda in PD-L1-high ...

We recently compiled a list of the 8 Good Stocks To Buy Right Now. In this article, we are going to take a look at where ...

Pharma companies also are known for paying dividends, offering you a guaranteed stream of annual revenue. Below are three ...

The HLTH 2024 conference will kick off Sunday in Las Vegas with an expected 12,000 attendees from across the industry to plot ...